Product Images Glycopyrrolate

Glycopyrrolate Injection USP is a medication that is distributed in a 1mL single-dose vial. The medication is made in India and is distributed by Zydus Pharmaceuticals (USA) Inc. It is not recommended to use in newborns and should be administered intramuscularly or intravenously. The vial contains benzyl alcohol and should be stored at a controlled room temperature between 20-25°C (68° to 17°F). The lot number is not available in the text.*

Glycopyrrolate Injection, USP is a medication manufactured by Zydus Pharmaceuticals (USA) Inc. in single-dose vials of 2.5 mL. It contains benzyl alcohol and is used to treat certain medical conditions. The recommended dosage is available in the package insert. The medication should be stored at controlled room temperatures ranging from 20°C to 25°C (68°F to 77°F). The text also includes information on the pH level adjustment of the medication.*

This is a prescription-only medication called Glycopyrrolate Injection used for intramuscular or intravenous administration. It comes in a single-dose vial of 2mL and is not suitable for newborns. The medication should be stored at a temperature between 20°C to 25°C, and it contains benzyl alcohol. The drug is distributed by Zydus Pharmaceuticals in the USA and is made in India. The expiration date of the medication is not available.*

This is a description of a medication called LESCIEEV, available as an injection with a 1mg/5mL dose. It contains the preservative NF (0.9% Benzyl Alcohol) and Glycopyrrolate. The pH value for this medication is adjusted with hydrochloric acid and/or sodium hydroxide. It is recommended to be stored at 20°C to 25°C (68°F to 77°F) and is distributed by Zydus Pharmaceuticals (USA) Inc. in a 5 mL multiple dose vial. This medication is not intended for use in newborns and is meant to be administered either intramuscularly or intravenously.*

This is a description of a medication package for Glycopyrrolate Injection, USP, with a strength of 1mg/5mL. It contains a total of 255ml in multiple dose vials. The medication is manufactured by Liva Pharmaceuticals Limited in Vadodara, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ. The package insert should be consulted for information on dosage, and the medication should be stored at a controlled room temperature.*

This is a description of a medication called "Glycopyrrolate Injection, USP" containing 4mg/20 (0.2 mg/mL) for intramuscular or intravenous administration. It comes in a 20 mL Multiple-Dose Vial and contains Benzyl Alcohol as a preservative. The pH is adjusted, if necessary, with hydrochloric acid and/or sodium hydroxide. The recommended dosage is available in the package insert. The medication should be stored at 20° to 25°C (68° to 77°F). It is distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ. The lot and expiration dates are also provided.*

Glycopyrrolate Injection, USP is not for use in newborns and it contains benzyl alcohol. It is administered intravenously or intramuscularly and comes in 10 x 20 mL multiple-dose vials. The usual dosage information can be found in the package insert. Store it at 20° to 25°C (68° to 77°F). The manufacturer is Liva Pharmaceuticals Ltd in Vadodara, India, and it is distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ 08534.*